Comparing outcomes in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration treated with two different doses of primary intravitreal bevacizumab: results of the pan-american collaborative retina study group (PACORES) at the 12-month follow-up

Lihteh WuJ. Fernando ArévaloMaurício MaiaMaría H. BerrocalJ. García SánchezTeodoro EvansTeodoro Evans2026-03-222026-03-22200910.1007/s10384-008-0622-yhttps://doi.org/10.1007/s10384-008-0622-yhttps://andeanlibrary.org/handle/123456789/49946Citaciones: 11enMacular degenerationChoroidal neovascularizationMedicineBevacizumabOphthalmologyRetinaNeovascularizationComparing outcomes in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration treated with two different doses of primary intravitreal bevacizumab: results of the pan-american collaborative retina study group (PACORES) at the 12-month follow-uparticle